000 01261 a2200337 4500
005 20250516175846.0
264 0 _c20140929
008 201409s 0 0 eng d
022 _a1533-1601
024 7 _a10.1177/0192623313505155
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrady, William M
245 0 0 _aMolecular alterations and biomarkers in colorectal cancer.
_h[electronic resource]
260 _bToxicologic pathology
_cJan 2014
300 _a124-39 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Humanized
_xtherapeutic use
650 0 4 _aBiomarkers, Tumor
_xblood
650 0 4 _aCetuximab
650 0 4 _aColorectal Neoplasms
_xblood
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aPanitumumab
650 0 4 _aPrognosis
650 0 4 _aProto-Oncogene Proteins
_xgenetics
650 0 4 _aSignal Transduction
700 1 _aPritchard, Colin C
773 0 _tToxicologic pathology
_gvol. 42
_gno. 1
_gp. 124-39
856 4 0 _uhttps://doi.org/10.1177/0192623313505155
_zAvailable from publisher's website
999 _c23219500
_d23219500